Who
David Thomson
EVP Genl Counsel & Secretary
Company insider
Files Form 4 as: EVP Genl Counsel & Secretary, MannKind.
In numbers
- Trades disclosed
- 290
- Buys
- 0
- Sells
- 70
- Bought
- $0
- Sold
- $8.8M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 17 Jan 2006
- Last trade
- 17 Jul 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jul 2026filed 17 Jul 2026 | MNKD MannKindPharmaceuticals | SEC FORM 4 Sold | $98K24,109 at $4.05 | filing |
| 17 Jul 2026filed 17 Jul 2026 | MNKD MannKindPharmaceuticals | SEC FORM 4 Sold | $98K24,109 at $4.05 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MNKD MannKindPharmaceuticals | SEC FORM 4 Code M | —93,790 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MNKD MannKindPharmaceuticals | SEC FORM 4 Code F | $211K51,632 at $4.09 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MNKD MannKindPharmaceuticals | SEC FORM 4 Code F | $52K12,662 at $4.09 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —93,790 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MNKD MannKindPharmaceuticals | SEC FORM 4 Code F | $73K17,754 at $4.09 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MNKD MannKindPharmaceuticals | SEC FORM 4 Code F | $67K16,378 at $4.09 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —93,790 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MNKD MannKindPharmaceuticals | SEC FORM 4 Code M | —93,790 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MNKD MannKindPharmaceuticals | SEC FORM 4 Code F | $211K51,632 at $4.09 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MNKD MannKindPharmaceuticals | SEC FORM 4 Code F | $52K12,662 at $4.09 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MNKD MannKindPharmaceuticals | SEC FORM 4 Code F | $73K17,754 at $4.09 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MNKD MannKindPharmaceuticals | SEC FORM 4 Code F | $67K16,378 at $4.09 | filing |
| 12 May 2026filed 13 May 2026 | MNKD MannKindPharmaceuticals | SEC FORM 4 Sold | $9,9793,033 at $3.29 | filing |
| 12 May 2026filed 13 May 2026 | MNKD MannKindPharmaceuticals | SEC FORM 4 Sold | $9,9793,033 at $3.29 | filing |
| 11 May 2026filed 13 May 2026 | MNKD MannKindPharmaceuticals | SEC FORM 4 Code F | $44K12,387 at $3.52 | filing |
| 11 May 2026filed 13 May 2026 | MNKD MannKindPharmaceuticals | SEC FORM 4 Code F | $44K12,387 at $3.52 | filing |
| 23 Mar 2026filed 25 Mar 2026 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —221,000 at $0.00 | filing |
| 23 Mar 2026filed 25 Mar 2026 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —217,000 at $0.00 | filing |
News
In Touch With Quinte – Belleville Mayoral Candidate Paul Fleming, Quinte West Mayoral Candidate David Thomson91x.fm · 16 Oct 2026MEET THE CANDIDATE: David Thomsonquintenews.com · 12 Oct 2026Comparing MannKind (NASDAQ:MNKD) & Iovance Biotherapeutics (NASDAQ:IOVA)MNKD · tickerreport.com · 15 Oct 2026MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)MNKD · manilatimes.net · 10 Oct 2026
2 headlines in the last 90 days name David Thomson; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.